CTMX

CytomX Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

18.9%

Short % Float

11.8d to cover · Moderate squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

FMR, LLC

Top Holder

14.7% of float

186.3M sh

Public Float

36/100

Dilution Score

Medium

20 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

36/100

MEDIUM

Inst: 1.06% · Top: FMR, LLC

Biotech Analytics

Biotech / Pharma

13.52

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk36

Clinical Trials8

Short Interest50